Background and Aim: Despite introducing the hepatitis B virus (HBV) vaccine, the incidence
of the Hepatitis B virus globally is still a major health concern. This systematic review and …

Hepatitis B virus (HBV) causes liver diseases (chronic hepatitis, cirrhosis, and hepatocellular
carcinoma) and is a leading health problem worldwide. Sequencing of the whole HBV …

Abstract Interleukin-35 (IL-35) is a new member of IL-12 family of cytokines, and its role in
pathogenesis of hepatitis B virus (HBV) infection has been recently suggested. Accordingly …

Background Genomic studies of hepatitis B virus (HBV) diversity are becoming increasingly
significant to understand how HBV mutations interact with a wide spectrum of clinical and …

Hepatitis B virus (HBV) complications include liver disease, cirrhosis, and cancer. Every
year, approximately one million people die as a result of HBV. Virus sequence homogeneity …

The study was carried out in Anbar from September to December 2022 with the aim of
identifying genetic variations in the IL-37 subunit gene among persons with chronic …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the sixth
most common cancer, the fourth most common cause of cancer-related death in the world …

Hepatitis B virus (HBV) infection is a global health challenge, and clearance or persistence
of HBV is mostly determined by host immune responses, Therefore, this study aimed to …

Background: To put it simply, hepatitis is liver inflammation. Hepatitis B virus (HBV) infection
is a public health problem because it can lead to serious liver conditions like hepatocellular …

Hepatitis B virus (HBV) infection is a public health concern because it causes liver diseases
such as hepatocellular carcinoma and liver cirrhosis. Depending on the virus sequence …